(Q43417440)

23 November 2017

title

Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia (English)

1 reference

23 November 2017

3

Toru Hiyama

1 reference

23 November 2017

Duc Trong Quach

1

1 reference

23 November 2017

Huy Minh Le

2

1 reference

23 November 2017

Oanh Thuy Nguyen

4

1 reference

23 November 2017

Trung Sao Nguyen

5

1 reference

23 November 2017

Naomi Uemura

6

1 reference

23 November 2017

publication date

20 November 2012

1 reference

23 November 2017

1 reference

23 November 2017

volume

18

1 reference

23 November 2017

issue

2

1 reference

23 November 2017

page(s)

151-157

1 reference

Is gastric cancer preventable?

23 November 2017

cites work

1 reference

Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands

21 January 2018

1 reference

Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up

21 January 2018

1 reference

Gastritis staging in clinical practice: the OLGA staging system

21 January 2018

1 reference

Assessment of atrophic gastritis using the OLGA system

21 January 2018

1 reference

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

The severity of endoscopic gastric atrophy could help to predict Operative Link on Gastritis Assessment gastritis stage.

21 January 2018

1 reference

OLGA staging for gastritis: a tutorial

21 January 2018

1 reference

Gastrointestinal epithelial neoplasia: Vienna revisited

21 January 2018

1 reference

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

21 January 2018

1 reference

Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings.

21 January 2018

1 reference

Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia

21 January 2018

1 reference

Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System

21 January 2018

1 reference

Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.

21 January 2018

1 reference

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

21 January 2018

1 reference

The long term results of endoscopic surveillance of premalignant gastric lesions

21 January 2018

1 reference

Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study

21 January 2018

1 reference

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".

21 January 2018

1 reference

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portug

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HEL.12027

1 reference

23 November 2017

1 reference